Telesis Bio enables researchers to eliminate outsourcing delays and boost productivity by enabling rapid, on-site synthesis of high-fidelity DNA and mRNA with its Gibson SOLA® platform. Designed to integrate with standard lab automation, Gibson SOLA gives scientists full control over build timelines and IP. From antibodies to cell therapies, innovators across biotech and pharma use Telesis Bio to accelerate development in synthetic biology and therapeutic discovery.